Oxbow Advisors LLC Makes New $8.16 Million Investment in Corteva, Inc. $CTVA

Oxbow Advisors LLC bought a new stake in Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 96,303 shares of the company’s stock, valued at approximately $8,156,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CTVA. BlackRock Inc. bought a new stake in shares of Corteva in the 2nd quarter worth approximately $4,560,180,000. Harris Associates L P grew its holdings in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Norges Bank bought a new position in Corteva during the fourth quarter valued at $504,001,000. Royal Bank of Canada increased its position in Corteva by 202.1% in the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in shares of Corteva in the second quarter valued at $392,447,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Up 2.6%

CTVA stock opened at $77.97 on Wednesday. The company’s 50 day moving average is $81.84 and its 200 day moving average is $80.12. The stock has a market cap of $52.02 billion, a price-to-earnings ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Morgan Stanley boosted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. BNP Paribas Exane lifted their target price on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Barclays boosted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Rothschild & Co Redburn raised their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Wells Fargo & Company lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.